Lactobacillus acidophilus KBL409 Ameliorates Atopic Dermatitis in a Mouse Model.

Atopic dermatitis Gut-skin axis Immune response Lactobacillus acidophilus Microbiota Probiotic

Journal

Journal of microbiology (Seoul, Korea)
ISSN: 1976-3794
Titre abrégé: J Microbiol
Pays: Korea (South)
ID NLM: 9703165

Informations de publication

Date de publication:
22 Feb 2024
Historique:
received: 20 08 2023
accepted: 27 12 2023
revised: 11 12 2023
medline: 22 2 2024
pubmed: 22 2 2024
entrez: 22 2 2024
Statut: aheadofprint

Résumé

Atopic dermatitis (AD) is a chronic inflammatory skin disease with repeated exacerbations of eczema and pruritus. Probiotics can prevent or treat AD appropriately via modulation of immune responses and gut microbiota. In this study, we evaluated effects of Lactobacillus acidophilus (L. acidophilus) KBL409 using a house dust mite (Dermatophagoides farinae)-induced in vivo AD model. Oral administration of L. acidophilus KBL409 significantly reduced dermatitis scores and decreased infiltration of immune cells in skin tissues. L. acidophilus KBL409 reduced in serum immunoglobulin E and mRNA levels of T helper (Th)1 (Interferon-γ), Th2 (Interleukin [IL]-4, IL-5, IL-13, and IL-31), and Th17 (IL-17A) cytokines in skin tissues. The anti-inflammatory cytokine IL-10 was increased and Foxp3 expression was up-regulated in AD-induced mice with L. acidophilus KBL409. Furthermore, L. acidophilus KBL409 significantly modulated gut microbiota and concentrations of short-chain fatty acids and amino acids, which could explain its effects on AD. Our results suggest that L. acidophilus KBL409 is the potential probiotic for AD treatment by modulating of immune responses and gut microbiota of host.

Identifiants

pubmed: 38386273
doi: 10.1007/s12275-024-00104-5
pii: 10.1007/s12275-024-00104-5
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : National Research Foundation of Korea
ID : NRF-2021R1I1A1A01048923
Organisme : National Research Foundation of Korea
ID : NRF-2022M3A9F3017371
Organisme : National Research Foundation of Korea
ID : NRF-2022M3A9F3017371
Organisme : National Research Foundation of Korea
ID : NRF-2022M3A9F3017371
Organisme : National Research Foundation of Korea
ID : NRF-2022M3A9F3017371
Organisme : National Research Foundation of Korea
ID : NRF-2022M3A9F3017371
Organisme : National Research Foundation of Korea
ID : NRF-2022M3A9F3017371
Organisme : National Research Foundation of Korea
ID : NRF-2022M3A9F3017371

Informations de copyright

© 2024. The Author(s).

Références

Canani, R. B., Costanzo, M. D., Leone, L., Pedata, M., Meli, R., & Calignano, A. (2011). Potential beneficial effects of butyrate in intestinal and extraintestinal diseases. World Journal of Gastroenterology, 17, 1519–1528.
pubmed: 21472114 pmcid: 3070119 doi: 10.3748/wjg.v17.i12.1519
Dai, Z. L., Wu, G., & Zhu, W. Y. (2011). Amino acid metabolism in intestinal bacteria: Links between gut ecology and host health. Frontiers in Bioscience, 16, 1768–1786.
doi: 10.2741/3820
David, L. A., Maurice, C. F., Carmody, R. N., Gootenberg, D. B., Button, J. E., Wolfe, B. E., Ling, A. V., Devlin, A. S., Varma, Y., Fischbach, M. A., et al. (2014). Diet rapidly and reproducibly alters the human gut microbiome. Nature, 505, 559–563.
pubmed: 24336217 doi: 10.1038/nature12820
Fang, Z., Li, L., Zhang, H., Zhao, J., Lu, W., & Chen, W. (2021). Gut microbiota, probiotics, and their interactions in prevention and treatment of atopic dermatitis: A review. Frontiers in Immunology, 12, 720393.
pubmed: 34335634 pmcid: 8317022 doi: 10.3389/fimmu.2021.720393
Fania, L., Moretta, G., Antonelli, F., Scala, E., Abeni, D., Albanesi, C., & Madonna, S. (2022). Multiple roles for cytokines in atopic dermatitis: From pathogenic mediators to endotype-specific biomarkers to therapeutic targets. International Journal of Molecular Sciences, 23, 2684.
pubmed: 35269828 pmcid: 8910412 doi: 10.3390/ijms23052684
Han, D. H., Kim, W. K., Lee, C., Park, S., Lee, K., Jang, S. J., & Ko, G. (2022). Co-administration of Lactobacillus gasseri KBL697 and tumor necrosis factor-alpha inhibitor infliximab improves colitis in mice. Scientific Reports, 12, 9640.
pubmed: 35688918 pmcid: 9187735 doi: 10.1038/s41598-022-13753-6
Hanifin, J. M., Thurston, M., Omoto, M., Cherill, R., Tofte, S. J., & Graeber, M. (2001). The eczema area and severity index (EASI): Assessment of reliability in atopic dermatitis. Experimental Dermatology, 10, 11–18.
pubmed: 11168575 doi: 10.1034/j.1600-0625.2001.100102.x
He, H., & Guttman-Yassky, E. (2019). JAK inhibitors for atopic dermatitis: An update. American Journal of Clinical Dermatology, 20, 181–192.
pubmed: 30536048 doi: 10.1007/s40257-018-0413-2
He, J., Zhang, P., Shen, L., Niu, L., Tan, Y., Chen, L., Zhao, Y., Bai, L., Hao, X., Li, X., et al. (2020). Short-chain fatty acids and their association with signalling pathways in inflammation, glucose and lipid metabolism. International Journal of Molecular Sciences, 21, 6356.
pubmed: 32887215 pmcid: 7503625 doi: 10.3390/ijms21176356
Jang, Y. J., Kim, W. K., Han, D. H., Lee, K., & Ko, G. (2019). Lactobacillus fermentum species ameliorate dextran sulfate sodium-induced colitis by regulating the immune response and altering gut microbiota. Gut Microbes, 10, 696–711.
pubmed: 30939976 pmcid: 6866707 doi: 10.1080/19490976.2019.1589281
Kang, H., Lee, C. H., Kim, J. R., Kwon, J. Y., Seo, S. G., Han, J. G., Kim, B. G., Kim, J. E., & Lee, K. W. (2015). Chlorella vulgaris attenuates dermatophagoides farinae-induced atopic dermatitis-like symptoms in NC/Nga mice. International Journal of Molecular Sciences, 16, 21021–21034.
pubmed: 26404252 pmcid: 4613239 doi: 10.3390/ijms160921021
Kim, D. Y., Jung, D. H., Song, E. J., Jang, A. R., Park, J. Y., Ahn, J. H., Lee, T. S., Kim, Y. J., Lee, Y. J., Seo, I. S., et al. (2022a). D-galactose intake alleviates atopic dermatitis in mice by modulating intestinal microbiota. Frontiers in Nutrition, 9, 895837.
pubmed: 35799581 pmcid: 9254681 doi: 10.3389/fnut.2022.895837
Kim, H., Nam, B. Y., Park, J., Song, S., Kim, W. K., Lee, K., Nam, T. W., Park, J. T., Yoo, T. H., Kang, S. W., et al. (2022b). Lactobacillus acidophilus KBL409 reduces kidney fibrosis via immune modulatory effects in mice with chronic kidney disease. Molecular Nutrition & Food Research, 66, 2101105.
doi: 10.1002/mnfr.202101105
Kim, W. K., Han, D. H., Jang, Y. J., Park, S., Jang, S. J., Lee, G., Han, H. S., & Ko, G. (2021). Alleviation of DSS-induced colitis via Lactobacillus acidophilus treatment in mice. Food & Function, 12, 340–350.
doi: 10.1039/D0FO01724H
Kim, W. K., Jang, Y. J., Han, D. H., Jeon, K., Lee, C., Han, H. S., & Ko, G. (2020). Lactobacillus paracasei KBL382 administration attenuates atopic dermatitis by modulating immune response and gut microbiota. Gut Microbes, 12, 1819156.
pubmed: 33016202 pmcid: 7553742 doi: 10.1080/19490976.2020.1819156
Kim, W. K., Jang, Y. J., Han, D. H., Seo, B., Park, S., Lee, C. H., & Ko, G. (2019a). Administration of Lactobacillus fermentum KBL375 causes taxonomic and functional changes in gut microbiota leading to improvement of atopic dermatitis. Frontiers in Molecular Biosciences, 6, 92.
pubmed: 31612141 pmcid: 6777006 doi: 10.3389/fmolb.2019.00092
Kim, W. K., Jang, Y. J., Seo, B., Han, D. H., Park, S., & Ko, G. (2019b). Administration of Lactobacillus paracasei strains improves immunomodulation and changes the composition of gut microbiota leading to improvement of colitis in mice. Journal of Functional Foods, 52, 565–575.
doi: 10.1016/j.jff.2018.11.035
Langille, M. G., Zaneveld, J., Caporaso, J. G., McDonald, D., Knights, D., Reyes, J. A., Clemente, J. C., Burkepile, D. E., Vega Thurber, R. L., Knight, R., et al. (2013). Predictive functional profiling of microbial communities using 16S rRNA marker gene sequences. Nature Biotechnology, 31, 814–821.
pubmed: 23975157 pmcid: 3819121 doi: 10.1038/nbt.2676
Lee, S. H., Yoon, J. M., Kim, Y. H., Jeong, D. G., Park, S., & Kang, D. J. (2016). Therapeutic effect of tyndallized Lactobacillus rhamnosus IDCC 3201 on atopic dermatitis mediated by down-regulation of immunoglobulin E in NC/Nga mice. Microbiology and Immunology, 60, 468–476.
pubmed: 27240551 doi: 10.1111/1348-0421.12390
Livak, K. J., & Schmittgen, T. D. (2001). Analysis of relative gene expression data using real-time quantitative PCR and the 2
pubmed: 11846609 doi: 10.1006/meth.2001.1262
Loy, A., Pfann, C., Steinberger, M., Hanson, B., Herp, S., Brugiroux, S., Gomes Neto, J. C., Boekschoten, M. V., Schwab, C., Urich, T., et al. (2017). Lifestyle and horizontal gene transfer-mediated evolution of Mucispirillum schaedleri, a core member of the murine gut microbiota. mSystems, 2, e00171–16.
Lucke, K., Miehlke, S., Jacobs, E., & Schuppler, M. (2006). Prevalence of Bacteroides and Prevotella spp. in ulcerative colitis. Journal of Medical Microbiology, 55, 617–624.
pubmed: 16585651 doi: 10.1099/jmm.0.46198-0
Marsella, R., & De Benedetto, A. (2017). Atopic dermatitis in animals and people: An update and comparative review. Veterinary Sciences, 4, 37.
pubmed: 29056696 pmcid: 5644664 doi: 10.3390/vetsci4030037
Matsuoka, H., Maki, N., Yoshida, S., Arai, M., Wang, J., Oikawa, Y., Ikeda, T., Hirota, N., Nakagawa, H., & Ishii, A. (2003). A mouse model of the atopic eczema/dermatitis syndrome by repeated application of a crude extract of house-dust mite Dermatophagoides farinae. Allergy, 58, 139–145.
pubmed: 12622745 doi: 10.1034/j.1398-9995.2003.23790.x
McNabney, S. M., & Henagan, T. M. (2017). Short chain fatty acids in the colon and peripheral tissues: A focus on butyrate, colon cancer, obesity and insulin resistance. Nutrients, 9, 1348.
pubmed: 29231905 pmcid: 5748798 doi: 10.3390/nu9121348
Meng, Y., Liu, Z., Zhai, C., Di, T., Zhang, L., Zhang, L., Xie, X., Lin, Y., Wang, N., Zhao, J., et al. (2019). Paeonol inhibits the development of 1-chloro-2,4-dinitrobenzene-induced atopic dermatitis via mast and T cells in BALB/c mice. Molecular Medicine Reports, 19, 3127–3229.
Neis, E. P., Dejong, C. H., & Rensen, S. S. (2015). The role of microbial amino acid metabolism in host metabolism. Nutrients, 7, 2930–2946.
pubmed: 25894657 pmcid: 4425181 doi: 10.3390/nu7042930
Palomares, O., Yaman, G., Azkur, A. K., Akkoc, T., Akdis, M., & Akdis, C. A. (2010). Role of Treg in immune regulation of allergic diseases. European Journal of Immunology, 40, 1232–1240.
pubmed: 20148422 doi: 10.1002/eji.200940045
Peng, W., & Novak, N. (2015). Pathogenesis of atopic dermatitis. Clinical & Experimental Allergy, 45, 566–574.
doi: 10.1111/cea.12495
Petersen, E. B. M., Skov, L., Thyssen, J. P., & Jensen, P. (2018). Role of the gut microbiota in atopic dermatitis: A systematic review. Acta Dermato-Venereologica, 99, 5–11.
Portincasa, P., Bonfrate, L., Vacca, M., De Angelis, M., Farella, I., Lanza, E., Khalil, M., Wang, D. Q., Sperandio, M., & Di Ciaula, A. (2022). Gut microbiota and short chain fatty acids: Implications in glucose homeostasis. International Journal of Molecular Sciences, 23, 1105.
pubmed: 35163038 pmcid: 8835596 doi: 10.3390/ijms23031105
Poulsen, L. K., & Hummelshoj, L. (2007). Triggers of IgE class switching and allergy development. Annals of Medicine, 39, 440–456.
pubmed: 17852040 doi: 10.1080/07853890701449354
Precup, G., & Vodnar, D. C. (2019). Gut Prevotella as a possible biomarker of diet and its eubiotic versus dysbiotic roles: A comprehensive literature review. British Journal of Nutrition, 122, 131–140.
pubmed: 30924428 doi: 10.1017/S0007114519000680
Rooks, M. G., & Garrett, W. S. (2016). Gut microbiota, metabolites and host immunity. Nature Reviews Immunology, 16, 341–352.
pubmed: 27231050 pmcid: 5541232 doi: 10.1038/nri.2016.42
Roucher, V. F., Desnots, E., Naël, C., Agnoux, A. M., Alexandre-Gouabau, M. C., Darmaun, D., & Boquien, C. Y. (2013). Use of UPLC-ESI-MS/MS to quantitate free amino acid concentrations in micro-samples of mammalian milk. Springerplus, 2, 622.
pubmed: 24298434 pmcid: 3841331 doi: 10.1186/2193-1801-2-622
Round, J. L., & Mazmanian, S. K. (2009). The gut microbiota shapes intestinal immune responses during health and disease. Nature Reviews Immunology, 9, 313–323.
pubmed: 19343057 pmcid: 4095778 doi: 10.1038/nri2515
Sánchez, B., Delgado, S., Blanco-Míguez, A., Lourenço, A., Gueimonde, M., & Margolles, A. (2017). Probiotics, gut microbiota, and their influence on host health and disease. Molecular Nutrition & Food Research, 61, 1600240.
doi: 10.1002/mnfr.201600240
Sawada, J., Morita, H., Tanaka, A., Salminen, S., He, F., & Matsuda, H. (2007). Ingestion of heat-treated Lactobacillus rhamnosus GG prevents development of atopic dermatitis in NC/Nga mice. Clinical & Experimental Allergy, 37, 296–303.
doi: 10.1111/j.1365-2222.2006.02645.x
Szegedi, K., Kremer, A. E., Kezic, S., Teunissen, M. B., Bos, J. D., Luiten, R. M., Res, P. C., & Middelkamp-Hup, M. A. (2012). Increased frequencies of IL-31-producing T cells are found in chronic atopic dermatitis skin. Experimental Dermatology, 21, 431–436.
pubmed: 22621183 doi: 10.1111/j.1600-0625.2012.01487.x
van Baarlen, P., Wells, J. M., & Kleerebezem, M. (2013). Regulation of intestinal homeostasis and immunity with probiotic lactobacilli. Trends in Immunology, 34, 208–215.
pubmed: 23485516 doi: 10.1016/j.it.2013.01.005
Vieira, P. L., Christensen, J. R., Minaee, S., O’Neill, E. J., Barrat, F. J., Boonstra, A., Barthlott, T., Stockinger, B., Wraith, D. C., & O’Garra, A. (2004). IL-10-secreting regulatory T cells do not express Foxp3 but have comparable regulatory function to naturally occurring CD4
pubmed: 15128781 doi: 10.4049/jimmunol.172.10.5986
Watanabe, S., Narisawa, Y., Arase, S., Okamatsu, H., Ikenaga, T., Tajiri, Y., & Kumemura, M. (2003). Differences in fecal microflora between patients with atopic dermatitis and healthy control subjects. Journal of Allergy and Clinical Immunology, 111, 587–591.
pubmed: 12642841 doi: 10.1067/mai.2003.105
Won, T. J., Kim, B., Lim, Y. T., Song, D. S., Park, S. Y., Park, E. S., Lee, D. I., & Hwang, K. W. (2011). Oral administration of Lactobacillus strains from Kimchi inhibits atopic dermatitis in NC/Nga mice. Journal of Applied Microbiology, 110, 1195–1202.
pubmed: 21338447 doi: 10.1111/j.1365-2672.2011.04981.x
Ye, S., Yan, F., Wang, H., Mo, X., Liu, J., Zhang, Y., Li, H., & Chen, D. (2021). Diversity analysis of gut microbiota between healthy controls and those with atopic dermatitis in a Chinese population. The Journal of Dermatology, 48, 158–167.
pubmed: 32860635 doi: 10.1111/1346-8138.15530

Auteurs

Woon-Ki Kim (WK)

Department of Environmental Health Sciences, Graduate School of Public Health, Seoul National University, Seoul, 08826, Republic of Korea. kimunki@snu.ac.kr.
Institute of Health and Environment, Seoul National University, Seoul, 08826, Republic of Korea. kimunki@snu.ac.kr.

You Jin Jang (YJ)

Department of Environmental Health Sciences, Graduate School of Public Health, Seoul National University, Seoul, 08826, Republic of Korea.

SungJun Park (S)

Department of Environmental Health Sciences, Graduate School of Public Health, Seoul National University, Seoul, 08826, Republic of Korea.
N-Bio, Seoul National University, Seoul, 08826, Republic of Korea.
KoBioLabs, Inc, Seoul, 08826, Republic of Korea.

Sung-Gyu Min (SG)

Department of Environmental Health Sciences, Graduate School of Public Health, Seoul National University, Seoul, 08826, Republic of Korea.

Heeun Kwon (H)

Department of Environmental Health Sciences, Graduate School of Public Health, Seoul National University, Seoul, 08826, Republic of Korea.

Min Jung Jo (MJ)

Department of Environmental Health Sciences, Graduate School of Public Health, Seoul National University, Seoul, 08826, Republic of Korea.

GwangPyo Ko (G)

Department of Environmental Health Sciences, Graduate School of Public Health, Seoul National University, Seoul, 08826, Republic of Korea.
Institute of Health and Environment, Seoul National University, Seoul, 08826, Republic of Korea.
N-Bio, Seoul National University, Seoul, 08826, Republic of Korea.
KoBioLabs, Inc, Seoul, 08826, Republic of Korea.

Classifications MeSH